2021
Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)
Veludhandi A, John T, Bakshi N, Arnold S, Bhatia M, Lane P, Meacham L, Khemani K, Chaudhury S, Olowoselu F, Kasow K, Hsieh M, Abraham A, Guilcher G, Krishnamurti L. Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR). Blood 2021, 138: 3030. DOI: 10.1182/blood-2021-152383.Peer-Reviewed Original ResearchHematopoietic cell transplantationSickle cell diseaseMuscle strengthCGVHD symptomsHCT recipientsCell transplantationPhysical fitnessYoung adultsPost-HCTChronic graftHost diseaseMarrow transplantationGrip strengthTUG scoresRisk factorsCell diseasePathophysiology of SCDJournal of ParenteralCardiometabolic risk factorsLong-term survivorsHand-grip dynamometryHand grip strengthCross-sectional studyHandgrip strength testYears of age
2018
A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease
Matthie N, Ross D, Sinha C, Khemani K, Bakshi N, Krishnamurti L. A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease. Journal Of The National Medical Association 2018, 111: 158-168. PMID: 30266214, PMCID: PMC6433553, DOI: 10.1016/j.jnma.2018.08.001.Peer-Reviewed Original ResearchConceptsSickle cell diseaseChronic pain managementChronic painChronic pain experiencePain managementCell diseasePain experienceChronic SCD painGreater QoL impairmentVaso-occlusive painYears of ageSelf-management strategiesSickle cell anemiaSubgroup of adultsSCD painAcute painPersistent painSubstantial morbidityHealthcare utilizationImpaired qualityQoL impairmentPainSCD managementCell anemiaQualitative study
2012
Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients
Cohen A, Krishnamurti L, Creary S. Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients. Blood 2012, 120: 3538. DOI: 10.1182/blood.v120.21.3538.3538.Peer-Reviewed Original ResearchAcute lymphoblastic leukemiaMedication adherenceMaintenance therapyAdherence surveyAdherence ratesHealthcare workersPediatric sickle cell populationMaintenance therapy phaseMedication adherence surveyWeekly oral methotrexateDisease-free survivalAnti-retroviral therapyPediatric leukemia patientsHigher adherence ratesNon-adherence ratesRisk of relapseSelf-reported adherenceCommon pediatric cancerSickle cell populationEnd of studyGood overall adherenceYears of ageIntravenous vincristineMMAS-4Month regimen
2010
Changing Age Distribution of Deep Venous Thrombosis In the United States
Viswanathan P, Krishnamurti L. Changing Age Distribution of Deep Venous Thrombosis In the United States. Blood 2010, 116: 1539. DOI: 10.1182/blood.v116.21.1539.1539.Peer-Reviewed Original ResearchDeep vein thrombosisNational Inpatient SampleDistribution of DVTDifferent age groupsPrincipal diagnosisHospitalized populationAge groupsPulmonary embolismSecondary diagnosisEpidemiology of hospitalizationsDeep venous thrombosisAge group 45Time of admissionICD-9 codesYears of agePublic health importanceAge distributionVein thrombosisHospitalized patientsVenous thrombosisGroup 45Total populationInpatient SampleHealth care researchNational utilizationProlonged QTc Interval Is Common In Patients with Sickle Cell Disease and Has An Inverse Relationship to Hemoglobin and Hematocrit: Results From CSSCD
Goel R, Rajderkar S, Padman R, Krishnamurti L. Prolonged QTc Interval Is Common In Patients with Sickle Cell Disease and Has An Inverse Relationship to Hemoglobin and Hematocrit: Results From CSSCD. Blood 2010, 116: 2675. DOI: 10.1182/blood.v116.21.2675.2675.Peer-Reviewed Original ResearchSickle cell diseaseProlonged QTcCardiac deathSCD patientsCell diseaseProlonged QTc intervalPremature cardiac deathSudden cardiac deathMultivariate logistic regressionYears of ageLead EKGEchocardiographic characteristicsHbSS patientsClinical courseQTc intervalProspective studyClinical centersHigh riskPatientsQTcStudy subjectsEstablished markerCooperative StudyLogistic regressionNational Institute
2008
Hematopoietic stem cell transplantation for hemoglobinopathies: Progress and prospects
Krishnamurti L, Gupta D. Hematopoietic stem cell transplantation for hemoglobinopathies: Progress and prospects. Indian Journal Of Medical And Paediatric Oncology 2008, 29: 39-48. DOI: 10.4103/0971-5851.51444.Peer-Reviewed Original ResearchSickle cell diseaseRisk factorsAllogeneic bone marrow transplantationClass IIHematopoietic stem cell transplantationClass ITransplant related morbidityUnrelated donor transplantsHLA-identical donorHLA-identical siblingsStem cell transplantationBone marrow transplantationCourse of diseaseLong-term survivalYears of ageAntithymocyte globulinAllogeneic SCTTransplant outcomesDonor transplantsRelated morbidityMarrow transplantationCell transplantationCell diseaseProbability of survivalTerm survival